Pancreatic adenocarcinoma. Clinical Practice Guidelines in Oncology.
Tempero
Margaret
M
UCSF Comprehensive Cancer Center.
Arnoletti
J Pablo
JP
Ben-Josef
Edgar
E
Bhargava
Pankaj
P
Casper
Ephraim S
ES
Kim
Paula
P
Malafa
Mokenge P
MP
Nakakura
Eric K
EK
Shibata
Stephen
S
Talamonti
Mark
M
Wang
Hanlin
H
Willett
Christopher
C
D000230:Adenocarcinoma / Q000175:diagnosis / Q000601:surgery; D000465:Algorithms; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D002779:Cholestasis / Q000209:etiology; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D019468:Disease Management; D004322:Drainage; D017219:Gastric Outlet Obstruction / Q000209:etiology; D006801:Humans; D008197:Lymph Node Excision; D009367:Neoplasm Staging / Q000145:classification; D010166:Palliative Care; D010180:Pancreatectomy; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000601:surgery; D011169:Portal Vein / Q000601:surgery; D018714:Radiotherapy, Adjuvant; D016896:Treatment Outcome; D000093542:Gemcitabine
D015295:Antigens, Tumor-Associated, Carbohydrate; D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine